>
  1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Logos Global Management LP Buys Olema Pharmaceuticals inc, Nkarta Inc, Kinnate Biopharma Inc, Sells Global Blood Therapeutics Inc, Keros Therapeutics Inc, Sarepta Therapeutics Inc

Investment company Logos Global Management LP (Current Portfolio) buys Olema Pharmaceuticals inc, Nkarta Inc, Kinnate Biopharma Inc, Apellis Pharmaceuticals Inc, Aligos Therapeutics Inc, sells Global Blood Therapeutics Inc, Keros Therapeutics Inc, Sarepta Therapeutics Inc, TG Therapeutics Inc, Celldex Therapeutics Inc during the 3-months ended 2020Q4, according to the most recent filings of the investment company, Logos Global Management LP. As of 2020Q4, Logos Global Management LP owns 44 stocks with a total value of $812 million. These are the details of the buys and sells.

For the details of Logos Global Management LP's stock buys and sells, go to https://www.gurufocus.com/guru/logos+global+management+lp/current-portfolio/portfolio

These are the top 5 holdings of Logos Global Management LP
  1. Olema Pharmaceuticals inc (OLMA) - 3,743,875 shares, 22.17% of the total portfolio. New Position
  2. Nkarta Inc (NKTX) - 1,682,178 shares, 12.73% of the total portfolio. New Position
  3. Forma Therapeutics Holdings Inc (FMTX) - 1,400,000 shares, 6.02% of the total portfolio. Shares added by 19.33%
  4. TG Therapeutics Inc (TGTX) - 850,000 shares, 5.45% of the total portfolio. Shares reduced by 51.43%
  5. Dyne Therapeutics Inc (DYN) - 1,604,392 shares, 4.15% of the total portfolio.
New Purchase: Olema Pharmaceuticals inc (OLMA)

Logos Global Management LP initiated holding in Olema Pharmaceuticals inc. The purchase prices were between $37.09 and $54.5, with an estimated average price of $46.89. The stock is now traded at around $48.550000. The impact to a portfolio due to this purchase was 22.17%. The holding were 3,743,875 shares as of 2020-12-31.

New Purchase: Nkarta Inc (NKTX)

Logos Global Management LP initiated holding in Nkarta Inc. The purchase prices were between $27.03 and $75.62, with an estimated average price of $41.72. The stock is now traded at around $55.630000. The impact to a portfolio due to this purchase was 12.73%. The holding were 1,682,178 shares as of 2020-12-31.

New Purchase: Kinnate Biopharma Inc (KNTE)

Logos Global Management LP initiated holding in Kinnate Biopharma Inc. The purchase prices were between $36.35 and $45.25, with an estimated average price of $40.13. The stock is now traded at around $35.160000. The impact to a portfolio due to this purchase was 2.79%. The holding were 569,602 shares as of 2020-12-31.

New Purchase: Apellis Pharmaceuticals Inc (APLS)

Logos Global Management LP initiated holding in Apellis Pharmaceuticals Inc. The purchase prices were between $30.79 and $57.2, with an estimated average price of $42.47. The stock is now traded at around $44.730000. The impact to a portfolio due to this purchase was 2.11%. The holding were 300,000 shares as of 2020-12-31.

New Purchase: Aligos Therapeutics Inc (ALGS)

Logos Global Management LP initiated holding in Aligos Therapeutics Inc. The purchase prices were between $13.2 and $32.74, with an estimated average price of $19.48. The stock is now traded at around $30.560000. The impact to a portfolio due to this purchase was 2.07%. The holding were 606,548 shares as of 2020-12-31.

New Purchase: IGM Biosciences Inc (IGMS)

Logos Global Management LP initiated holding in IGM Biosciences Inc. The purchase prices were between $47.41 and $115.03, with an estimated average price of $70.2. The stock is now traded at around $98.370000. The impact to a portfolio due to this purchase was 1.63%. The holding were 150,000 shares as of 2020-12-31.

Added: Cogent Biosciences Inc (COGT)

Logos Global Management LP added to a holding in Cogent Biosciences Inc by 184.52%. The purchase prices were between $9.36 and $13.01, with an estimated average price of $11.02. The stock is now traded at around $9.620000. The impact to a portfolio due to this purchase was 1.73%. The holding were 1,920,500 shares as of 2020-12-31.

Added: Larimar Therapeutics Inc (LRMR)

Logos Global Management LP added to a holding in Larimar Therapeutics Inc by 116.67%. The purchase prices were between $14.28 and $25.06, with an estimated average price of $20.11. The stock is now traded at around $18.790000. The impact to a portfolio due to this purchase was 1.02%. The holding were 715,000 shares as of 2020-12-31.

Added: KalVista Pharmaceuticals Inc (KALV)

Logos Global Management LP added to a holding in KalVista Pharmaceuticals Inc by 63.33%. The purchase prices were between $12.97 and $19.47, with an estimated average price of $17.22. The stock is now traded at around $42.100000. The impact to a portfolio due to this purchase was 0.45%. The holding were 490,000 shares as of 2020-12-31.

Sold Out: Global Blood Therapeutics Inc (GBT)

Logos Global Management LP sold out a holding in Global Blood Therapeutics Inc. The sale prices were between $37.65 and $63.77, with an estimated average price of $49.17.

Sold Out: Sarepta Therapeutics Inc (SRPT)

Logos Global Management LP sold out a holding in Sarepta Therapeutics Inc. The sale prices were between $125.56 and $178.74, with an estimated average price of $148.28.

Sold Out: Celldex Therapeutics Inc (CLDX)

Logos Global Management LP sold out a holding in Celldex Therapeutics Inc. The sale prices were between $14.99 and $22.75, with an estimated average price of $18.05.

Sold Out: Cytokinetics Inc (CYTK)

Logos Global Management LP sold out a holding in Cytokinetics Inc. The sale prices were between $15.26 and $28.61, with an estimated average price of $18.21.

Sold Out: Sage Therapeutics Inc (SAGE)

Logos Global Management LP sold out a holding in Sage Therapeutics Inc. The sale prices were between $58.41 and $89.06, with an estimated average price of $73.93.

Sold Out: Akouos Inc (AKUS)

Logos Global Management LP sold out a holding in Akouos Inc. The sale prices were between $17.03 and $22.44, with an estimated average price of $19.44.



Here is the complete portfolio of Logos Global Management LP. Also check out:

1. Logos Global Management LP's Undervalued Stocks
2. Logos Global Management LP's Top Growth Companies, and
3. Logos Global Management LP's High Yield stocks
4. Stocks that Logos Global Management LP keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
wigbertHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)